| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51662-1475-1 | 51662-1475 | HUMAN PRESCRIPTION DRUG | VECURONIUM BROMIDE | VECURONIUM BROMIDE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20191215 | N/A | ANDA | ANDA075164 | HF Acquisition Co LLC, DBA HealthFirst | VECURONIUM BROMIDE | 1 mg/mL | 10 mL in 1 VIAL (51662-1475-1) |
| 0409-1632-01 | 0409-1632 | HUMAN PRESCRIPTION DRUG | Vecuronium Bromide | Vecuronium Bromide | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20060228 | 20250630 | ANDA | ANDA075164 | Hospira, Inc. | VECURONIUM BROMIDE | 1 mg/mL | 10 VIAL in 1 CARTON (0409-1632-01) / 10 mL in 1 VIAL (0409-1632-21) |